Ozempic Expert: They’re Lying To You About The Side Effects!
- Thread starter gollumtroll
- Start date
Thats okay, we have another drug for that. Its called viagra/cialis.
So now you're on two drugs
There's now a new term called "Ozempic face". You will lose weight, but you'll also look like an AIDS patient
www.dailymail.co.uk
Celebs suffering from gauntness amid 'Ozempic face' crisis
Many faced accusations they had 'Ozempic face' early this year after stepping out on the red carpet with slimmed down profiles. But fans now say more celebrities have been hit with the look, typified by sunken eyes, gaunt cheeks and sagging skin.
Capitalism always finds a way...Thats okay, we have another drug for that. Its called viagra/cialis.
So now you're on two drugs
For the record, I have no opinion on the health effects, positive, negative, short or long term of Ozempic or the other semiglutides.
After all, the benefit of losing weight was a "side effect" of this type of diabetic medication.
I recall the Fen-Phen drug rush of the 1990's. I had an MD friend who lost a lot of weight from it and lived a long life. Died in an accident at 78. Never any of the heart valve issues that resulted it being pulled off the market by the FDA. You know, the same FDA these conspiracy kooks insist are just a runner stamp in the pocket of Big Pharma!
Slippery Slope: Fen-Phen Users Recall a 'Miracle' Turned Nightmare
— Fen-phen use was linked to heart valve damage, as these two cases illustrate.
www.medpagetoday.com
In the mid 1990s, Phyllis Hardy was eager to try the new "miracle medicine" that co-workers at her hospital in Milwaukee were using to effortlessly shed pounds.
At the time, she was in her late 30s and weighed more than 300 pounds. Her doctor prescribed the combination drug fenfluramine and phentermineopens in a new tab or window -- known as "fen-phen" -- and within a few months she had lost more than 25 pounds.
"When you are fat, you just want to lose weight," Hardy said, then added. "I haven't been right since."
In 1997, the FDA ordered Wyeth to remove fenfluramine (Pondimin) and a related drug, dexfenfluramine (Redux) from the market, after a study showed they caused damage to heart valvesopens in a new tab or window. That effectively put an end to the fen-phen craze.
Hardy, now 57, believes fen-phen -- which she took for several months -- caused her to develop a leaky heart valve.
She takes heart medications that address her symptoms, including drugs that slow her heart rate and lower her blood pressure. She gets winded at times and said she has had a burning sensation in the throat ever since using the drugs.
Fen-phen is one of many weight-loss treatments that gained rapid popularity, only to be pulled from pharmacy shelves when problems were revealed.
After all, the benefit of losing weight was a "side effect" of this type of diabetic medication.
I recall the Fen-Phen drug rush of the 1990's. I had an MD friend who lost a lot of weight from it and lived a long life. Died in an accident at 78. Never any of the heart valve issues that resulted it being pulled off the market by the FDA. You know, the same FDA these conspiracy kooks insist are just a runner stamp in the pocket of Big Pharma!
Slippery Slope: Fen-Phen Users Recall a 'Miracle' Turned Nightmare
— Fen-phen use was linked to heart valve damage, as these two cases illustrate.
Slippery Slope: Fen-Phen Users Recall a 'Miracle' Turned Nightmare
Fen-phen use was linked to heart valve damage, as these two cases illustrate.
www.medpagetoday.com
In the mid 1990s, Phyllis Hardy was eager to try the new "miracle medicine" that co-workers at her hospital in Milwaukee were using to effortlessly shed pounds.
At the time, she was in her late 30s and weighed more than 300 pounds. Her doctor prescribed the combination drug fenfluramine and phentermineopens in a new tab or window -- known as "fen-phen" -- and within a few months she had lost more than 25 pounds.
"When you are fat, you just want to lose weight," Hardy said, then added. "I haven't been right since."
In 1997, the FDA ordered Wyeth to remove fenfluramine (Pondimin) and a related drug, dexfenfluramine (Redux) from the market, after a study showed they caused damage to heart valvesopens in a new tab or window. That effectively put an end to the fen-phen craze.
Hardy, now 57, believes fen-phen -- which she took for several months -- caused her to develop a leaky heart valve.
She takes heart medications that address her symptoms, including drugs that slow her heart rate and lower her blood pressure. She gets winded at times and said she has had a burning sensation in the throat ever since using the drugs.
Fen-phen is one of many weight-loss treatments that gained rapid popularity, only to be pulled from pharmacy shelves when problems were revealed.
Graphic reveals ALL of Ozempic's weird side effects
Despite their undeniable slimming effects, injections of semaglutide - branded as Ozempic and Wegovy - have been linked to a catalogue of side effects from the embarrassing to potentially life-threatening.
As I mentioned before, my diabetic wife has been taking Ozempic for 2 years. Her side effects have been slight loss of weight and nothing else. Considering she must inject herself ONCE A WEEK, compared to twice a day every day with insulin, it is an excellent drug. Oh, and she doesn't have to worry about erectile distinction, LOL.
Graphic reveals ALL of Ozempic's weird side effects
Despite their undeniable slimming effects, injections of semaglutide - branded as Ozempic and Wegovy - have been linked to a catalogue of side effects from the embarrassing to potentially life-threatening.
It's great if it helps them lose weight. But it's total BS, that there are shortages of a medication for people with a physiological because of people who can't control their lifestyle. It's those people who should have to wait or get a decreased amount, not the diabetics.
Okay bro, how tall are you and........how quickly did you drop those 300lbs.
I find it fascinating you managed your weight that quickly.
Not everyone one can do it, in that time span
My friend is the same. She lost more weight kayaking one summer then did on this. When used for its intended purpose by the true people who suffer, a lot of these side effects don’t happen. It is people taking it for the side effects that experience more then they bargained for.
Why? are you now only injecting her with it once a week instead of twice a day?
LOL.Why? are you now only injecting her with it once a week instead of twice a day?
Why? are you now only injecting her with it once a week instead of twice a day?
Nathalie Niddam has one of the best podcasts out there. Canadian gal from Toronto.
She goes into the hard areas...Excellent breakdown of Semiglutide and Tirzepatide.
Talking about side effects. This a brand new drug, I would wait some years to take it. The problem is that if you stop taking it you gain the weight back, its not a cure.
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
People who take Ozempic and Wegovy may have a higher risk of developing a rare eye condition that can cause blindness, according to a new study, but more research is needed.
The study, published July 3 in JAMA Opthamology, found that patients with diabetes who were prescribed semaglutide — the ingredient in Ozempic and Wegovy — were more than four times more likely to develop a condition called non-arthritic anterior ischemic optic neuropathy, or NAION, as NBC News, Reuters and CNN reported.
In a statement to the news outlets, Novo Nordisk, the company that manufactures Ozempic and Wegovy, said, “Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from the use of our medicines very seriously."
NAION is a condition that can cause sudden and permanent blindness that has no known treatment. The new study was prompted by doctors at Mass Eye and Ear after they noted three cases in one week in patients using semaglutide medications, per CNN. Researchers analyzed data and medical records from 16,827 patients in the Boston area between 2017 and 2023.
Still, said researchers, "future study is required to assess causality" between the ingredient semaglutide and NAION.
:max_bytes(150000):strip_icc():focal(807x272:809x274)/ozempic-death-091323-tout-867467b8b3e64d7f99cfb6996ba5250d.jpg)
people.com
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
People who take Ozempic and Wegovy may have a higher risk of developing a rare eye condition that can cause blindness, according to a new study, but more research is needed.
The study, published July 3 in JAMA Opthamology, found that patients with diabetes who were prescribed semaglutide — the ingredient in Ozempic and Wegovy — were more than four times more likely to develop a condition called non-arthritic anterior ischemic optic neuropathy, or NAION, as NBC News, Reuters and CNN reported.
In a statement to the news outlets, Novo Nordisk, the company that manufactures Ozempic and Wegovy, said, “Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from the use of our medicines very seriously."
NAION is a condition that can cause sudden and permanent blindness that has no known treatment. The new study was prompted by doctors at Mass Eye and Ear after they noted three cases in one week in patients using semaglutide medications, per CNN. Researchers analyzed data and medical records from 16,827 patients in the Boston area between 2017 and 2023.
Still, said researchers, "future study is required to assess causality" between the ingredient semaglutide and NAION.
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
A study published in JAMA Opthamology on July 3 suggested a potential link between a rare eye condition, non-arthritic anterior ischemic optic neuropathy, or NAION, and diabetes patients who take Ozempic, Wegovy and similar weight-loss drugs — but study authors say more research is needed.
So, on the one hand researchers cannot determine for certain whether semaglutide causes NAION. But on the other hand, it does show an association. A monumental contradiction indeed.Talking about side effects. This a brand new drug, I would wait some years to take it. The problem is that if you stop taking it you gain the weight back, its not a cure.
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
People who take Ozempic and Wegovy may have a higher risk of developing a rare eye condition that can cause blindness, according to a new study, but more research is needed.
The study, published July 3 in JAMA Opthamology, found that patients with diabetes who were prescribed semaglutide — the ingredient in Ozempic and Wegovy — were more than four times more likely to develop a condition called non-arthritic anterior ischemic optic neuropathy, or NAION, as NBC News, Reuters and CNN reported.
In a statement to the news outlets, Novo Nordisk, the company that manufactures Ozempic and Wegovy, said, “Patient safety is a top priority for Novo Nordisk, and we take all reports about adverse events from the use of our medicines very seriously."
NAION is a condition that can cause sudden and permanent blindness that has no known treatment. The new study was prompted by doctors at Mass Eye and Ear after they noted three cases in one week in patients using semaglutide medications, per CNN. Researchers analyzed data and medical records from 16,827 patients in the Boston area between 2017 and 2023.
Still, said researchers, "future study is required to assess causality" between the ingredient semaglutide and NAION.
Ozempic and Wegovy May Be Linked to Increased Risk of Rare Form of Blindness — but More Research Is Needed
A study published in JAMA Opthamology on July 3 suggested a potential link between a rare eye condition, non-arthritic anterior ischemic optic neuropathy, or NAION, and diabetes patients who take Ozempic, Wegovy and similar weight-loss drugs — but study authors say more research is needed.
Semaglutide is being used by millions to control diabetes-2. Now, another version has been developed for diabetes-1 patients who inject insulin sometimes several times a day to only inject once a week, a phenomenal outcome indeed. So someone should inform Dr. Rizzo to get his facts straight before shooting his mouth off.
